Biogen (BIIB) call put ratio 1 call to 1 put into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St set to open lower as oil, bond yields tick up
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
Biogen (BIIB) Tops Q2 EPS by 43c, Beats on Revenue; Offers FY26 EPS Guidance
July 29, 2026 6:07 AM EDTBiogen (NASDAQ: BIIB) reported Q2 EPS of $3.60, $0.43 better than the analyst estimate of $3.17. Revenue for the quarter came in at $2.74 billion versus the consensus estimate of $2.43 billion.
GUIDANCE:
Biogen sees FY2026 EPS of $12.00-$13.00, versus the consensus of $12.72.
For earnings history and earnings-related data on Biogen (BIIB) click here.
... More